Helse Vest’s reasearch and innovation awards

Helse Vest RHF annually awards two prizes: a research prize and an innovation prize. The prizes will be awarded at the annual Research Conference in the autumn, and we encourage the various research environments in K2 to apply.

Helse Vest’s research award

The award is given to a researcher, research environment or young researcher (under the age of 40) who, through his or her research, has contributed to strengthening a research field or a research-based health service offering. The research must be of a nature and standard of significance for the level of research and / or the service offer in the region. Candidates (researcher, research environment or young researcher) who have contributed to the development of either a) research area, b) research collaboration / environment or c) who through their research have improved clinical practice in Helse Vest can be proposed.

The following form (Norwegian only): Forslagsskjema 2020- forskingspris og innovasjonspris should be filled in by the proposer.

Helse Vest’s annual research prize consists of NOK 200,000 and a work of art. The prize amount will be used for further research.

Helse Vest’s innovation award

The innovation prize is awarded to one or more persons who, through their work, have contributed to the development of a new or improved product, service, production process or organizational form that constitutes a concept that can be reused in the health sector. The award can be given both on the basis of research-driven and demand-driven innovation. The development must be made visible through the idea / innovation project being either reported and / or further developed together with the regional office of Innovation Norway, InnoMed, the Research Council of Norway or one of the region’s two Technology Transfer Offices (TTO). Similarly, internal projects that have not been made visible through the mentioned actors will also be considered. In such cases, it will be important that the product, process or services have been used, and it can be demonstrated to what benefit the innovation has had for the hospital.

A separate form (Norwegian only): Forslagsskjema 2020- forskingspris og innovasjonspris has been prepared to be filled in by the proposer.

The innovation award consists of NOK 100,000 and a work of art. The prize amount will be used for further innovation work.

Continue reading

Norwegian: Unngå identitetstyveri!

Visste du at flerfaktor-autentisering er den mest effektive måten å beskytte seg mot identitetstyveri?
Dette vil hindre at noen kan logge inn på kontoen din selv om passordet ditt skulle komme på avveie.

IT-Avdelingen ved UiB tilbyr flerfaktor-autentisering til alle ansatte og studenter. Den gjelder i første omgang Office 365 og VPN; flere tjenester vil bli lagt til fortløpende.

Aktiver flerfaktor-autentisering på kontoen din NÅ ved å gå inn på it.uib.no/MFA.

New positions: PhD-position and Postdoctoral Research Fellow

15 PhD-positions and 3 Postdoctoral Research Fellows are available from the Faculty of Medicine starting 1 February 2021 with application deadline 20 September 2020.

PhD-position: https://www.jobbnorge.no/en/available-jobs/job/191844/phd-position-15-positions

Postdoctoral: https://www.jobbnorge.no/en/available-jobs/job/191826/postdoctoral-research-fellow-3-positions

Continue reading

Master projects for the biomedical students 2020-2021

The program committee on the Institute of Biomedicine want the scientific staff to offer master projects for the biomedical students. The project will take place from the fall 2021 to the spring of 2022. Please use MAL Projectdescription.

We will arrange an event for students and supervisors during this semester. The students will get a chance to meet potential supervisors, and the scientists get the opportunity to present their research. We will send out details about this later. We hope you want to attend this! More information: VEILEDER INFO_

Please send your master projects by 18th of September to siri.aaserud@uib.no or to studie@biomed.uib.no.

Norwegian: Gjesteforelesning: SLE – disease mechanisms, clinical features and prognosis

Gjesteforelesning på K2 og Avdeling for Reumatologi, 10. september 2020, kl 15:00

SLE – disease mechanisms, clinical features and prognosis

Foredragsholder: Professor og overlege Anders Bengtsson, Lunds Universitet og Skånes Universitetssjukhus

Professor Bengtsson er en av Sverige ledende revmatologer med systemisk lupus erytematosus (SLE) som spesialfelt. På torsdag holder han en state-of-the-art forelesning om SLE.

For å få tilsendt lenke / møteinvitasjon til foredraget, vennligst registrer deg på følgende skjemaker:

https://skjemaker.app.uib.no/view.php?id=8906286

This week`s employee – Simona Chera

What are you working on?

I work as an associate professor at the Center for Diabetes Research, K2. My research is directed at how cell death features govern the type of regenerative strategy employed by a biological system. By coupling classical and newly generated murine models of cell loss with genetic cell tracing, timed conditional gene expression and omics assays (transcriptomics, proteomics, scRNAseq), I study the dynamic molecular fingerprint of pancreatic islet cells decay and regeneration, with focus on self-renewal and global regulators of cell identity maintenance processes. Besides the in vivo approach, I use patient-specific induced pluripotent stem cells (hiPSC) as disease models coupled with large-scale imaging and omics for studying islet cell fate acquisition and maintenance. We are also developing a 3D culture system to investigate the influence of mechanical forces and adhesion on signaling pathways controlling the pancreatic progenitors’ differentiation potential. Our goal is to enlarge the knowledge base about pancreatic islet biology in order to create a better treatment for diabetes, or preventive measures in the future. My personal goal is to induce at least a certain level of endogenous regeneration of the pancreatic islets as seen in highly regenerative animals (like hydra, salamander or fish). My career started by working on such a successful regenerative system, and during my PhD work at University of Geneva, we described that apoptotic cells resulted upon injury were the source of regenerative signals. During my postdoctoral work (University of Geneva), I started working on pancreatic islet regeneration and showed that the mammalian pancreas also exhibits, at a very low level, an endogenous regenerative capacity. A better understanding of how islet cells are formed during development will also improve future regenerative strategies.

What do you enjoy working with at K2?

I started working here five years ago, which gave me the opportunity to get to know the tools and needs of clinical research. I am part of a very heterogeneous multidisciplinary group of researchers, integrating genomics, molecular and cellular biology, bioinformatics and clinical research. We all study diabetes but different aspects of the disease from the molecular mechanisms to clinical aspects. I like the challenge of learning how to effectively communicate with scientists from different disciplines, and to see the diabetes research from so many other points of view. Being so close to the clinics at K2 also changed my perspective over my own research, especially regarding motivation and impact.

New publications

Here are recent publications with contributions from K2 based on last week’s search on PubMed (and optionally articles that have not been included in previous lists). This time the list includes in total 7 recent publications. The entries appear in the order they were received from NCBI. If you have publications that are not included in this or previous lists, please send the references to Oda Barth Vedøy.

Continue reading

Employee interviews

It is time for the annual employee interviews. These are a part of targeted management and employee development. Therefore, the annual, systematic and mutually prepared personal conversations are between an employee and the immediate superior. All employees who have a main position at UiB must have employee interviews. This also includes fellows. For employees with a 10-20% position, the manager can agree with the employee that it is not necessary.

New this year is that it is not enough that the employee interviews are offered – they must also be carried out. Due to the ongoing coronavirus pandemic, I think a phone call or digital meeting can be fine in cases where for various reasons it can be difficult to complete the call with physical attendance.

Employee interviews are an important arena for clarifying expectations for performance, providing mutual feedback, and insight into each other’s work situation and addressing the work environment and conditions at the workplace. The conversation will be linked to K2’s strategic plans and be a real and results-oriented management tool for achieving set goals.

Elements related to life phase can be addressed as a theme. The conversation will also be used to uncover competence needs, change and development. The content of the employee interview must be focused on matters the manager and employee can do something about.

It is important to communicate what you want to achieve in the employee interview and facilitate the confidentiality needed for the interview to have added value for both parties. This can be a gradual process that can take some time to develop.

For foreign employees, it is important to be aware of their need to understand overall strategies and goals for the university, the importance of a good and inclusive work environment, and the individual’s opportunities for contribution to the community. Relevant topics can also be their social network, trust vis-à-vis the manager and colleagues, experience of belonging, and in some cases facilitation and integration also outside the workplace.

As a natural part of the performance appraisal and clarification of expectations, conversation about salary conditions is included as part of the employee interview. It is then important to remember that we have established systems for wage negotiations.

As Head of Department, I am responsible for ensuring that all employees conduct annual employee interviews and am responsible for ensuring that the results of the interviews are included in K2’s plans and budget. It is not possible to carry this out for all K2’s employees, hence the conduct of the interviews is delegated. I have employee interviews with the research group leaders, while they in turn are responsible for their group members. When it comes to administrative staff, head of administration Julie Stavnes is responsible.

Time is short and suddenly it’s Christmas. It is therefore a good idea to start the employee interviews as soon as possible. Good luck!

Norwegian: Informasjonsmøte om mottak BOTT økonomi 03.09.

Det medisinske fakultet er i gang med å forberede mottaket av nye økonomisystem knyttet til BOTT. Vi har nedsatt en styringsgruppe og en arbeidsgruppe som skal se hvordan vi arbeider med økonomi i dag og hvordan innføringen av nye systemer påvirker økonomitjenesten og økonomiarbeidet ved fakultetet.

I dette møtet presenterer vi arbeidet vårt så langt for alle interesserte ved fakultetet. Vi vil gå gjennom mandatet og tidsplanen for endringsarbeidet, og det vil være anledning til å stille spørsmål til arbeidsgruppen.

Les mer om prosjektet her: https://www.uib.no/med/137379/bott-økonomi-ved-det-medisinske-fakultet

Møtet arrangeres i Zoom. Påmeldte vil få tilsendt lenke dagen før møtet.

Påmelding her: https://www.uib.no/en/node/137918

This week`s employee – Anne Hammer Knudsen

I have been employed as a technician at UiB since December 1999, last century! I was employed in the research laboratory at the children’s clinic, with Lage Aksnes as my first boss. Among other things, there was analysis of vitamin A,D,E, celiac disease, ulcerative colitis, morbus crohn and Pancreas Elastase 1 in the faeces. And, some method development as well.
Before coming here, I worked in the laboratory at the Vinmonopolet. I took my education at the Statens Næringsmiddeltekniske skole, where I became a Næringsmiddelteknolog. So, I am neither a chemist nor a molecular biologist, but the lab work is much the same, although the quantities are different. At the Vinmonopolet it went in liters, here it goes in microliters.
I am currently employed at the Center for Diabetes Research. I have been here since 2014, when the research lab at the children’s clinic was closed. I have been given new, interesting assignments and had to learn new methods. A bit demanding at times, but very nice to learn new things. I also want to brag about my great colleagues, a joy to work with.
I am also a safety delegate, since 2010, and substitute representative for chief Safety delegate at MED-FAK since 2017. By saying yes to that position, I have become acquainted with new colleagues at all faculties, both at UiB and the rest of the country’s universities. Every fall, the Hovedverneombudskonferansen is organized, which all HVO and their substitute representative can attend. The conference goes on a tour of the universities.
As you may realize, I am doing well here at K2, varied work assignments and great colleagues! Have a nice weekend!

New publications

Here are recent publications with contributions from K2 based on last week’s search on PubMed (and optionally articles that have not been included in previous lists). This time the list includes in total 9 recent publications. The entries appear in the order they were received from NCBI. If you have publications that are not included in this or previous lists, please send the references to Oda Barth Vedøy.

Continue reading

Hi everyone!

The semester is already well underway with some different teaching in the Corona era. I encourage all instructors to join the Teams group “K2 digital teaching” which contains a lot of useful information and is a platform for experience exchange.

Also this year, UiB has announced infrastructure funding with a framework of NOK 15 million. The Faculty of Medicine can submit 3 applications. It is the dean of research, Marit Bakke, and research leaders from the institutes who rank the applications and choose the 3 to be sent to the university. The guidelines can be found here (Veileder Forskningsinfrastruktur 2021). In short, the following applies:

  1. Each application can be a maximum of 4 MNOK
  2. Own financing of at least 20% (of application sum) is required
  3. The faculty has set aside 1 MNOK to cover parts of this
  4. If two faculties join together, the application sum can be 8 million. Note that the application must be among the three applications submitted by both faculties.

The application form can be found here (Søknadsskjema). Applications from K2 are sent to me (silke.appel@uib.no) and ranked by the leader group. Application deadline is 7/9.

Norwegian: Status som merittert underviser – 2020 – ny søknadsfrist

Som et ledd i arbeidet for studiekvalitet har fakultetsstyret opprettet en meritteringsordning for fremragende undervisere ved Det medisinske fakultet.

Fakultetet inviterer med dette sine undervisere til å søke om å bli tildelt merittert undervisningsstatus. Merittert status tildeles vitenskapelig ansatte som har vist betydningsfull innsats for å sikre utdanningskvalitet i bred forstand.

Søknadsfrist er 1. oktober 2020.

For mer informasjon om meritteringsordningen og søknadskravene se: Utlysning meritteringsordning 2020 og Krav til søknad om status som merittert underviser

Web based course CCBIO905 Methods in Cancer Biomarker Research, fall 2020

We are happy to invite you to CCBIO’s course CCBIO905 Methods in Cancer Biomarker Research, October 27-29, 2020. This will be run online through Zoom, so you can join from the comfort of your home, or your home universities. Although the course is mainly intended for PhD students and Master students, admission is open for others who find this course interesting.

CCBIO905 is a 5 ECTS course with focus on the full panel of advanced and standard methods with relevance for cancer biomarkers. The intention is a methodological course that also includes components of ethics and economy.

The thematic parts include methods ranging from basic techniques on nucleotides and proteins to more advanced approaches, as well as bioinformatics and bio-banking. The course will focus on methods to study tissue samples, blood samples, urine samples, and other biologic materials, like immunohistochemistry, in situ hybridization, PCR-techniques and sequencing, Western blot and ELISA, microarray methods, proteomics, circulating tumor cells and DNA, flow cytometry, bioinformatics and biobanks. Changes in nucleic acids and proteins in different settings will also be covered.

Program: See the preliminary scientific program here. Continue reading

Web based course CCBIO907 Cancer-related vascular biology, fall 2020

We have the pleasure of inviting you to a web based CCBIO course: CCBIO907 Cancer-related vascular biology, September 21 – October 2, 2020

The course will be held through a digital platform (Zoom), also the group assignments, so you can attend even from the comfort of your own home. Although the course is mainly intended for PhD students and Master students, admission is open for others who find this course interesting.

CCBIO907 is a 6 ECTS course that provides broad theoretical and practical understanding of basic aspects of vascular biology, cancer-related vascular biology, and other processes and diseases where vascular biology is relevant. The course presents knowledge about relationships between vascular biology, cancer progression, and diagnostic and treatment options directed towards the vasculature. Applied methods for studying vascular biology and biomarkers reflecting cancer-related vascular biology are taught. Also, the course aims to stimulate to scientific thinking, critical election and professional discussions.

CCBIO907 is part of the CCBIO-Harvard INTPART collaboration, and participants attending this course will have the rear opportunity to benefit from the knowledge of researchers who have been in the frontline of vascular biology research for decades, and who are experienced lecturers at Harvard Medical School. This year, you will get to meet Edward R. Smith, Joyce Bischoff and Hong Cheng in addition to Randy Watnick and Mike Rogers.

Program: See the preliminary scientific program here.

Continue reading

This week`s employee – Monika Ringdal

I completed my education at NTNU in Trondheim in molecular cell biology. I moved to Bergen after my studies and was lucky to get a job in Pål Njølstad’s MODY group in 2016. Today, the organization has changed a bit, but I still belong to the MODY group and am affiliated with the Center for Diabetes Research. MODY (Maturity Onset Diabetes of the Young) is still an important part of the work.
The group consists of both UIB and hospital employees. The close association with Haukeland University Hospital makes the work extra interesting and meaningful. I feel very lucky to get to work here with incredibly talented and very nice colleagues, which makes it very nice to be at work.

New publications

Here are recent publications with contributions from K2 based on last week’s search on PubMed (and optionally articles that have not been included in previous lists). This time the list includes in total 5 recent publications. The entries appear in the order they were received from NCBI. If you have publications that are not included in this or previous lists, please send the references to Oda Barth Vedøy.

Continue reading

Guidelines for this autumns dissertations

The faculty has made new guidelines for this autumns dissertations;

– Full digital disputations are still recommended. By fully digital we mean a solution where everyone involved, including the candidate, is disputing from their own home or office (with private or UiB equipment).
– The faculty allows for the use of suitable UiB premises by agreement with the relevant department. This is particularly relevant if the candidate only has access to the Helse-Bergen PC. If UiB premises are used, supervisors, as well as any committee chair and custos may be in the same room as the candidate. Opponents are not allowed to be physically present, even in cases where they are already in Bergen. Note that custos and committee chairmen must then have an opportunity to retire to attend the digital committee meeting, so that their own (brought) equipment is required for this. You can use a laptop, tablet or similar, but note that this must also be tested.
– PhD coordinator or other representatives from the administration can not be expected to be physically present, but will be available digitally and facilitate testing and implementation.
– Everyone who has an active role in the disputation must participate in testing in advance, with the equipment and in the room they will be staying at the disputation itself. Everyone who has an active role during the disputation must become well acquainted with the equipment through testing.
– IT assistant can be physically present as long as they do not work from home office. This is ordered via UiB help.
– Zoom webinar is the recommended solution from UiB Central. The IT department is working to get more licenses in place, probably from October. We will keep you updated on progress, but until further notice, UiBhjelp can be used to order the use of the license.
– The department will not provide food, tablecloths, cloaks or flowers to the room where the candidate is staying.
– It will not be possible to invite the public into the disputation room, even if the size of the room should indicate that it is possible.
– The faculty will offer administrative support to the departments on dates where one department has two disputations on the same day, but we will try as much as possible to avoid collisions.

Questions? Please contact Irene Hjelmaas

Welcome back to a new semester!

I hope everyone had a great holiday. Most people have probably vacationed here in Norway and perhaps seen with new eyes how beautiful and exciting our country is?

Corona virus
As you know, there is currently an increased spread of coronavirus and the government is now slowing down the reopening of our society. Dean Per Bakke has recently sent an email what this means for employees at the Faculty of Medicine. The use of home office is delegated to the department level (K2).

  • Who can have a home office?
    The main rule is that all employees must go to work. This especially applies to the laboratories.

Home office may be relevant for those who are in risk groups or to relieve public transport. This must be agreed with your closest leader (Research Group Leader or Julie Stavnes for administrative staff). It is assumed that the work tasks can actually be performed at home.
Risk groups: Elderly employees over the age of 65 years, employees with underlying chronic diseases such as cardiovascular disease, diabetes, cancer, drug-induced immune deficiency, or chronic lung, liver, or kidney disease (https://www.fhi.no/en/id/infectious-diseases/coronavirus/).

  • How to behave when traveling in from abroad?
    Since we work in a hospital environment, we must follow Helse Bergen’s guidelines.

Red countries: You must be quarantined but testing for SARS-CoV-2 is not required. The exception is if special circumstances indicate that you must start work before the expiry of the quarantine period (then two negative tests are required at least 48 hours apart and the last test at least five days after income).

Yellow countries: If you have been in a yellow country for the last 10 days, you must test yourself. As a general rule, you should not go to work until a negative test result is obtained. If your closest leader still deems it necessary, you can – if you are healthy – go to work with a facemask until the test result is ready.

In both cases, you should inform your closest leader before returning to work.

  • Where can I test myself?
    Those who also have a position in Helse Bergen should test themselves in the parking garage at Haukeland hotel (open 08.30-11, tel. 55976160).

Those who only have a UiB affiliation are recommended using your GP (fastlege), the local emergency room (legevakt,) or contact Head of Administration Julie Savnes for information about UiB’s system (https://www.uib.no/en/ir/137267/testing-covid-19-employees-uib-coming-abroad).

The Olav Thon Foundation’s prizes and project funds in science and medicine 2021
The Olav Thon Foundation has announced up to three awards for outstanding teaching and a support scheme for student-active research projects in science and medicine for 2021

  • Award for excellent teaching
    The prize for outstanding teaching can be awarded to academic staff who teach at universities and colleges in Norway in combined positions. Persons with adjunct positions (bistilling) can also be proposed. The price is personal, and amounts to NOK 500,000. There is a requirement for student affiliation in the nomination.
  • Financial support for student-active research projects
    Support can be given to research projects in medicine and / or science that are actively brought into the education as an element in «student-active research. Amounts that can be awarded are up to NOK 830,000 per year for a maximum of three years.

Further information can be found in the appendix Thonpriser_undervisning_2020. Nominations must be sent to K2 by 19 August (mette.vesterhus@uib.no). We will pass on the nominations to the Faculty.